1.
Clin Kidney J
; 6(4): 418-20, 2013 Aug.
Article
in English
| MEDLINE
| ID: mdl-27293571
ABSTRACT
We report a case of renal thrombotic microangiopathy (TMA) in a myeloproliferative variant of hypereosinophilic syndrome (HES) in a 24-year-old man which resolved with imatinib therapy. This is one of a few cases in the literature to date describing TMA in HES, suggesting that the pathogenesis of thrombosis is at least in part related to damage from activated eosinophils.